Gene · 4920
Papers2,066
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,066
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In silico analysis reveals mir-98-5p as a potential inhibitor of tumor cell proliferation and metastasis in colorectal cancer by targeting the fzd3 receptor of the Wnt signaling pathway. | J Genet Eng Biotechnol | 2023 | 37466730 | PubTator, text mining | PubMed |
| Helicobacter pylori-activated fibroblasts as a silent partner in gastric cancer development. | Cancer Metastasis Rev | 2023 | 37460910 | PubTator, text mining | PubMed |
Wnt/β-catenin signaling pathway inhibitors, glycyrrhizic acid, solanine, polyphyllin I, crocin, hypericin, tubeimoside-1, diosmin, and rutin in medicinal plants have better binding affinities and anticancer properties: Molecular docking and ADMET study. | Food Sci Nutr | 2023 | 37457177 | PubTator, text mining | PubMed |
| Extracellular vesicle-associated tyrosine kinase-like orphan receptors ROR1 and ROR2 promote breast cancer progression. | Cell Commun Signal | 2023 | 37430307 | PubTator, text mining | PubMed |
| Long noncoding RNAs, glucose metabolism and cancer (Review). | Oncol Lett | 2023 | 37427347 | PubTator, text mining | PubMed |
| Wnt4 increases the thickness of the epidermis in burn wounds by activating canonical Wnt signalling and decreasing the cell junctions between epidermal cells. | Burns Trauma | 2023 | 37408701 | PubTator, text mining | PubMed |
| ROR1-STAT3 signaling contributes to ovarian cancer intra-tumor heterogeneity. | Cell Death Discov | 2023 | 37400436 | PubTator, text mining | PubMed |
| Wnt signaling: Essential roles in osteoblast differentiation, bone metabolism and therapeutic implications for bone and skeletal disorders. | Genes Dis | 2023 | 37397540 | PubTator, text mining | PubMed |
| Reviewing the Regulators of COL1A1. | Int J Mol Sci | 2023 | 37373151 | PubTator, text mining | PubMed |
| Perturbation Analysis of a Prognostic DDX3X-Mediated Gene Expression Signature Identifies the Antimetastatic Potential of Chaetocin in Hepatocellular Carcinoma. | Cells | 2023 | 37371098 | PubTator, text mining | PubMed |
| Effect of Marine-Derived Saccharides on Human Skin Fibroblasts and Dermal Papilla Cells. | Mar Drugs | 2023 | 37367655 | PubTator, text mining | PubMed |
| MTX-13, a Novel PTK7-Directed Antibody-Drug Conjugate with Widened Therapeutic Index Shows Sustained Tumor Regressions for a Broader Spectrum of PTK7-Positive Tumors. | Mol Cancer Ther | 2023 | 37352387 | PubTator, text mining | PubMed |
| Role of non‑coding RNA intertwined with the Wnt/β‑catenin signaling pathway in endometrial cancer (Review). | Mol Med Rep | 2023 | 37350380 | PubTator, text mining | PubMed |
| GNL3 and PA2G4 as Prognostic Biomarkers in Prostate Cancer. | Cancers (Basel) | 2023 | 37345060 | PubTator, text mining | PubMed |
| Profiling and targeting cancer stem cell signaling pathways for cancer therapeutics. | Front Cell Dev Biol | 2023 | 37305676 | PubTator, text mining | PubMed |
| Role of Vitamin D in Head and Neck Cancer-Immune Function, Anti-Tumour Effect, and Its Impact on Patient Prognosis. | Nutrients | 2023 | 37299554 | PubTator, text mining | PubMed |
| Precision Medicine to Treat Urothelial Carcinoma-The Way Forward. | Cancers (Basel) | 2023 | 37296985 | PubTator, text mining | PubMed |
| Awakening of Dormant Breast Cancer Cells in the Bone Marrow. | Cancers (Basel) | 2023 | 37296983 | PubTator, text mining | PubMed |
| Wingless/It/β-catenin signaling in liver metastasis from colorectal cancer: A focus on biological mechanisms and therapeutic opportunities. | World J Gastroenterol | 2023 | 37274070 | PubTator, text mining | PubMed |
| Bioactive profiling and evaluation of anti-proliferative and anti-cancerous properties of Shivagutika, an Indian polyherbal formulation synchronizing in vitro and in silico approaches. | Front Chem | 2023 | 37265589 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4920/papers?page=10